Last reviewed · How we verify

Stannous Fluoride Dentifrice

Procter and Gamble · FDA-approved active Small molecule

Stannous fluoride strengthens tooth enamel and inhibits bacterial acid production to prevent dental caries and reduce plaque formation.

Stannous fluoride strengthens tooth enamel and inhibits bacterial acid production to prevent dental caries and reduce plaque formation. Used for Dental caries prevention, Plaque reduction, Gingivitis prevention.

At a glance

Generic nameStannous Fluoride Dentifrice
SponsorProcter and Gamble
Drug classTopical fluoride dentifrice
TargetTooth enamel (hydroxyapatite); bacterial cell membranes
ModalitySmall molecule
Therapeutic areaDental/Oral Health
PhaseFDA-approved

Mechanism of action

Stannous ions bind to tooth enamel to form a protective fluorapatite layer that resists demineralization, while also having antimicrobial properties that reduce plaque-forming bacteria and their acid production. The fluoride component provides additional caries protection by promoting remineralization of early enamel lesions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: